Health Care Delivery - Publications - Faculty & Research

February 2022
Case

Cleveland Clinic Abu Dhabi: Leading Through the Fog of the COVID-19 Pandemic

As COVID-19 began to take lives, destroy healthcare systems, and shut down economies across the globe, Dr. Rakesh Suri, Chief Executive Officer of Cleveland Clinic Abu Dhabi, and his executive team adapted their leadership to instill the new levels of agility and... View Details

Citation

Educators

Purchase

Article

Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations

By: Zoe Chance and Rohit Deshpandé

It is more than mere coincidence that the highest rates of HIV occur in the world's poorest countries. Of the over 40 million people currently living with HIV, 95 percent are in the developing world. The first part of this paper explores the economics of HIV and... View Details

Keywords: Health Disorders; Developing Countries and Economies; Poverty; Health Care and Treatment; Social Marketing; Perspective; Customer Focus and Relationships; Profit; Africa; Asia; South America

Citation

Find at Harvard

Read Now

May 4, 2023
Article

Falling Insulin Prices—What Just Happened?

By: Leemore S. Dafny

Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details

Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry

Citation

Find at Harvard

Register to Read

January 2018
Article

Innovation Incentives and Biomarkers

By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra

Previously, we have discussed the importance of economic incentives in shaping markets for precision medicines. Here we consider incentives for biomarker development, including discovery and establishment. Biomarkers can reveal valuable information regarding diagnosis... View Details

Keywords: Health Care and Treatment; Innovation and Invention; Research and Development; Markets

Citation

Find at Harvard

Purchase

May 2011
Article

Nonsimultaneous Chains and Dominos in Kidney Paired Donation—Revisited

By: Itai Ashlagi, Duncan S. Gilchrist, Alvin E. Roth and Michael A. Rees

Since 2008 kidney exchange in America has grown in part from the incorporation of non-directed donors in transplant chains rather than simple exchanges. It is controversial whether these chains should be performed simultaneously ("domino paired donation," DPD) or... View Details

Keywords: ABO Incompatibility; Allosensitization; Paired Kidney Exchange; Regional Sharing; Simulation Models; Transplantation Policy; Health Care and Treatment; Supply Chain; Risk and Uncertainty; Logistics; United States

Citation

Find at Harvard

Read Now

03 Nov 2015
First Look

November 3, 2015

November 2015 Quarterly Journal of Economics Behavioral Hazard in Health Insurance By: Baicker, Katherine, Sendhil Mullainathan, and Joshua Schwartzstein Abstract—A fundamental implication of standard moral hazard models is overuse of... View Details

Keywords: Sean Silverthorne

15 Mar 2011
First Look

First Look: March 15

tax policy. Teams and Team Effectiveness in Health Services Organizations Authors:Bruce J. Fried, Sharon Topping, and Amy C. Edmondson Publication:In Health Care Management:... View Details

Keywords: Sean Silverthorne

2021
Working Paper

Regulatory Approval and Expanded Market Size

By: Benjamin Berger, Amitabh Chandra and Craig Garthwaite

Regulatory review of new medicines is often viewed as a hindrance to innovation by increasing the hurdle to bring products to market. However, a more complete accounting of regulation must also account for its potential market expanding effects through quality... View Details

Keywords: New Medicines; Regulatory Approval; Health Care and Treatment; Research and Development; Governing Rules, Regulations, and Reforms; Markets; Expansion; Pharmaceutical Industry

Citation

Find at Harvard

Read Now

04 Nov 2002
What Do You Think?

What’s Best for the Corporate Brain?

are the long-term memory of the corporate brain." Most respondents, in one way or another and without mentioning it explicitly, suggested strong linkages between the health of the corporate brain and the organizational culture of... View Details

Keywords: by James Heskett

March 2022
Article

Where to Locate COVID-19 Mass Vaccination Facilities?

By: Dimitris Bertsimas, Vassilis Digalakis Jr, Alexander Jacquillat, Michael Lingzhi Li and Alessandro Previero

The outbreak of COVID-19 led to a record-breaking race to develop a vaccine. However, the limited vaccine capacity creates another massive challenge: how to distribute vaccines to mitigate the near-end impact of the pandemic? In the United States in particular, the new... View Details

Keywords: Vaccines; COVID-19; Health Care and Treatment; Health Pandemics; Performance Effectiveness; Analytics and Data Science; Mathematical Methods

Citation

Read Now

01 Feb 2022
What Do You Think?

Is Concierge Management an Answer to the “Big Quit”?

(iStockphoto/Mladen Zivkovic) Several years ago, my spouse and I turned to concierge medicine. We no longer wanted to deal with a US health care system that often provides basically anonymous, production... View Details

Keywords: by James Heskett

08 Dec 2008
Research & Ideas

Thinking Twice About Supply-Chain Layoffs

manager changes his or her hours, it can upset a delicate balance of work schedules, family commitments, and child care, which in turn can derail increasingly fragile family budgets. In a survey of Wal-Mart employees, for instance, scheduling even beat out View Details

Keywords: by Julia Hanna; Retail

08 May 2020
In Practice

Nonprofits Hurt by COVID-19 Must Hoard Cash to Hold On

your non-tangible assets to show appreciation, which might be as mundane as providing staff with recreational opportunities to relieve stress. Showing that you care can sometimes make a critical difference in the organization’s ability to... View Details

Keywords: by Danielle Kost

August 2008 (Revised September 2008)
Case

The Flaxil Label (B)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States

Citation

Educators

Purchase

August 2021
Teaching Note

IBM Watson at MD Anderson Cancer Center

By: Shane Greenstein and Mel Martin

Teaching Note for HBS Case No. 621-022. View Details

Keywords: Decision Making; Technological Innovation; Innovation Strategy; Knowledge Management; Knowledge Use and Leverage; Operations; Failure; Information Technology; Applications and Software; Health Care and Treatment; Product Development; Health Industry; Health Industry; Health Industry; United States; Houston; Texas

Citation

Purchase

September 2018
Article

Discretionary Task Ordering: Queue Management in Radiological Services

By: Maria Ibanez, Jonathan R. Clark, Robert S. Huckman and Bradley R. Staats

Work-scheduling research typically prescribes task sequences implemented by managers. Yet employees often have discretion to deviate from their prescribed sequence. Using data from 2.4 million radiological diagnoses, we find that doctors prioritize similar tasks... View Details

Keywords: Discretion; Scheduling; Queue; Healthcare; Learning; Experience; Decentralization; Operations; Service Operations; Service Delivery; Performance; Performance Effectiveness; Performance Efficiency; Performance Improvement; Performance Productivity; Decisions; Time Management; Cost vs Benefits; Health Industry

Citation

SSRN

Find at Harvard

December 5, 2024
Article

A Consensus Definition of Creativity in Surgery: A Delphi Study Protocol

By: Alex Thabane, Tyler McKechnie, Phillip Staibano, Vikram Arora, Goran Calic, Jason W. Busse, Sameer Parpia and Mohit Bhandari

Introduction
Clear definitions are essential in science, particularly in the study of abstract phenomena like creativity. Due to its inherent complexity and domain-specific nature, the study of creativity has been complicated, as evidenced by the various... View Details

Keywords: Creativity; Health Care and Treatment; Outcome or Result; Measurement and Metrics

Citation

Register to Read

May 2023 (Revised June 2023)
Supplement

Novartis (B): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi

This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details

Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry

Citation

Article

Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures.

By: Ariel Dora Stern

The use of biomarkers holds great promise for the development of new therapeutics and the acceleration of clinical research. However, biomarkers must be validated—a complex and costly endeavor. Importantly, biomarker validation is meaningfully shaped by economic and... View Details

Keywords: Biomarkers; Information Management; Health Care and Treatment; Motivation and Incentives

Citation

Find at Harvard

Read Now